{"id":"https://openalex.org/W2886156783","doi":"https://doi.org/10.1158/1538-7445.am2018-2865","title":"Abstract 2865: Ciclopirox olamine: A common antifungal agent that inhibits growth of esophageal tumor cells in vitro and in vivo","display_name":"Abstract 2865: Ciclopirox olamine: A common antifungal agent that inhibits growth of esophageal tumor cells in vitro and in vivo","publication_year":2018,"publication_date":"2018-07-01","ids":{"openalex":"https://openalex.org/W2886156783","doi":"https://doi.org/10.1158/1538-7445.am2018-2865","mag":"2886156783"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2018-2865","doi":"https://doi.org/10.1158/1538-7445.am2018-2865","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-2865","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050446740","display_name":"Randi J. Ryan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I146416000","display_name":"University of Kansas","ror":"https://ror.org/001tmjg57","country_code":"US","type":"education","lineage":["https://openalex.org/I146416000"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Randi J. Ryan","raw_affiliation_strings":["University of Kansas, Kansas City, KS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Kansas, Kansas City, KS","institution_ids":["https://openalex.org/I146416000"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072004481","display_name":"Prabhu Ramamoorthy","orcid":"https://orcid.org/0000-0002-1963-6004","observed_orcids":["https://orcid.org/0000-0002-1963-6004"]},"institutions":[{"id":"https://openalex.org/I146416000","display_name":"University of Kansas","ror":"https://ror.org/001tmjg57","country_code":"US","type":"education","lineage":["https://openalex.org/I146416000"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Prabhu Ramamoorthy","raw_affiliation_strings":["University of Kansas, Kansas City, KS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Kansas, Kansas City, KS","institution_ids":["https://openalex.org/I146416000"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029226618","display_name":"Dharmalingam Subramaniam","orcid":"https://orcid.org/0000-0002-2710-485X","observed_orcids":["https://orcid.org/0000-0002-2710-485X"]},"institutions":[{"id":"https://openalex.org/I146416000","display_name":"University of Kansas","ror":"https://ror.org/001tmjg57","country_code":"US","type":"education","lineage":["https://openalex.org/I146416000"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dharmalingam Subramaniam","raw_affiliation_strings":["University of Kansas, Kansas City, KS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Kansas, Kansas City, KS","institution_ids":["https://openalex.org/I146416000"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035668092","display_name":"Shrikant Anant","orcid":"https://orcid.org/0000-0003-4193-3053","observed_orcids":["https://orcid.org/0000-0003-4193-3053"]},"institutions":[{"id":"https://openalex.org/I146416000","display_name":"University of Kansas","ror":"https://ror.org/001tmjg57","country_code":"US","type":"education","lineage":["https://openalex.org/I146416000"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shrikant Anant","raw_affiliation_strings":["University of Kansas, Kansas City, KS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Kansas, Kansas City, KS","institution_ids":["https://openalex.org/I146416000"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002299630","display_name":"Scott James Weir","orcid":"https://orcid.org/0000-0002-8020-434X","observed_orcids":["https://orcid.org/0000-0002-8020-434X"]},"institutions":[{"id":"https://openalex.org/I146416000","display_name":"University of Kansas","ror":"https://ror.org/001tmjg57","country_code":"US","type":"education","lineage":["https://openalex.org/I146416000"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott Weir","raw_affiliation_strings":["University of Kansas, Kansas City, KS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Kansas, Kansas City, KS","institution_ids":["https://openalex.org/I146416000"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I146416000"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"78","issue":"13_Supplement","first_page":"2865","last_page":"2865"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10619","display_name":"Esophageal Cancer Research and Treatment","score":0.9585000276565552,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10619","display_name":"Esophageal Cancer Research and Treatment","score":0.9585000276565552,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.013799999840557575,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ciclopirox-olamine","display_name":"ciclopirox olamine","score":0.9959999918937683},{"id":"https://openalex.org/keywords/esophageal-squamous-cell-carcinoma","display_name":"esophageal squamous cell carcinoma","score":0.9319999814033508},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.8709999918937683},{"id":"https://openalex.org/keywords/g0-g1-cell-cycle-arrest","display_name":"G0/G1 cell cycle arrest","score":0.8560000061988831},{"id":"https://openalex.org/keywords/cdk4","display_name":"CDK4","score":0.8790000081062317},{"id":"https://openalex.org/keywords/cdk6","display_name":"CDK6","score":1.0},{"id":"https://openalex.org/keywords/beta-catenin","display_name":"\u03b2-catenin","score":0.7900000214576721},{"id":"https://openalex.org/keywords/xenograft-tumor-growth-inhibition","display_name":"xenograft tumor growth inhibition","score":0.75},{"id":"https://openalex.org/keywords/esophageal-cancer-cell-lines","display_name":"esophageal cancer cell lines","score":0.6800000071525574},{"id":"https://openalex.org/keywords/clonogenicity","display_name":"clonogenicity","score":0.6589999794960022},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.6610000133514404},{"id":"https://openalex.org/keywords/dna-repair-inhibition","display_name":"DNA repair inhibition","score":0.6650000214576721},{"id":"https://openalex.org/keywords/head-and-neck-cancer","display_name":"head and neck cancer","score":0.45500001311302185}],"concepts":[{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6583005785942078},{"id":"https://openalex.org/C2775934118","wikidata":"https://www.wikidata.org/wiki/Q424169","display_name":"Propidium iodide","level":4,"score":0.6185585856437683},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5286983251571655},{"id":"https://openalex.org/C2779707156","wikidata":"https://www.wikidata.org/wiki/Q5611758","display_name":"Growth inhibition","level":3,"score":0.47551897168159485},{"id":"https://openalex.org/C103637391","wikidata":"https://www.wikidata.org/wiki/Q5308921","display_name":"Drug repositioning","level":3,"score":0.43554559350013733},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.42864394187927246},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.42295822501182556},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.40345507860183716},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.345422625541687},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.3199506402015686},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3020200729370117},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.23966515064239502},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2018-2865","doi":"https://doi.org/10.1158/1538-7445.am2018-2865","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-2865","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7154541134","https://openalex.org/W2924821449","https://openalex.org/W2017847041","https://openalex.org/W2327769516","https://openalex.org/W2389192421","https://openalex.org/W2917593365","https://openalex.org/W2377313294","https://openalex.org/W2070388523","https://openalex.org/W4213279091","https://openalex.org/W3083331731"],"abstract_inverted_index":{"Abstract":[0],"Esophageal":[1],"carcinoma":[2,340],"continues":[3],"to":[4,22,91,132,234,324,373,416,428],"carry":[5],"a":[6,23,58,203,227,281,309,344],"poor":[7],"prognosis":[8],"due":[9],"presentation":[10],"at":[11],"advanced":[12],"stages.":[13],"Current":[14],"chemotherapeutics":[15],"often":[16],"only":[17],"prolong":[18],"survival":[19],"for":[20,41,53,108,173,251,291,343,488],"months":[21],"few":[24],"years.":[25],"Drug":[26],"repositioning":[27],"is":[28,61,72,89,162,320],"an":[29,73],"important":[30],"pharmacologic":[31],"strategy":[32],"that":[33,76,143,303,317,381,398,469],"involves":[34],"investigation":[35],"and":[36,60,97,122,157,198,225,239,245,286,392,478],"implementation":[37],"of":[38,43,57,66,87,94,135,149,208,214,232,267,328,356,363,366,385,404,409,418,432,472,484],"known":[39],"drugs":[40],"treatment":[42,242,304],"new":[44],"diseases.":[45],"This":[46,159],"method":[47],"significantly":[48],"reduces":[49],"the":[50,55,80,83,133,171,184,206,230,270,296,318,354,419,430,438,485],"costs":[51],"required":[52],"establishing":[54],"safety":[56],"drug":[59,67,104,172,319],"associated":[62],"with":[63,170,196,211,221,243,263,305,360],"higher":[64],"rates":[65],"approval.":[68],"Ciclopirox":[69,463],"olamine":[70,145],"(CPX)":[71],"antifungal":[74,467],"agent":[75,468],"has":[77,105],"been":[78,106],"on":[79,137,183,269,434],"market":[81],"since":[82],"1970s.":[84],"The":[85,176,265,407],"mechanism":[86,408],"action":[88],"believed":[90],"include":[92],"disruptions":[93],"DNA":[95],"repair":[96],"cell":[98,152,185,223,271,292,339,341,401,411],"division":[99],"signals.":[100],"Recently,":[101],"however,":[102],"this":[103,322],"studied":[107],"its":[109],"antitumor":[110],"properties":[111],"demonstrated":[112,163,192],"in":[113,205,229,248,260,283,284,308,311,313,347,390,393,437,442,476,479],"human":[114],"rhabdomyosarcoma,":[115],"breast":[116],"carcinoma,":[117,121],"colon":[118],"adenocarcinoma,":[119],"bladder":[120],"hematologic":[123],"malignancies.":[124],"To":[125],"date,":[126],"there":[127],"are":[128,273,289],"no":[129],"studies":[130],"related":[131,415],"effect":[134],"CPX":[136,244,268,306,367,382,399,433],"esophageal":[138,151,337,386,473],"cancer.":[139],"Here,":[140],"we":[141,332,378,426],"show":[142],"ciclopirox":[144],"causes":[146],"growth":[147,160,326,384,471],"inhibition":[148,161,327,412],"four":[150],"lines:":[153],"TE-10,":[154],"SKGT4,":[155],"FLO1":[156],"ESO1.":[158],"by":[164,193,276],"hexosaminidase":[165],"assay":[166,217],"performed":[167,220],"after":[168,237],"incubation":[169,247],"24-72":[174],"h.":[175],"IC50":[177],"values":[178],"range":[179],"between":[180],"5-20\u00b5M":[181],"depending":[182],"line":[186,224,342],"used.":[187],"Cell":[188,254],"death":[189],"was":[190,218],"also":[191,219,301],"immunofluorescent":[194],"staining":[195],"Hoschst":[197],"propidium":[199],"iodide,":[200],"which":[201,288,348],"shows":[202],"decrease":[204,228,282,310],"number":[207],"viable":[209],"cells":[210,233,261,350,388,444,475],"increasing":[212],"concentrations":[213],"CPX.":[215,264],"Clonogenicity":[216],"each":[222],"demonstrates":[226,257],"ability":[231],"form":[235],"colonies":[236],"24":[238],"48":[240],"hour":[241],"subsequent":[246],"standard":[249],"media":[250],"5-7":[252],"days.":[253],"cycle":[255,272,293,402],"analysis":[256,279],"G0/G1":[258,297],"arrest":[259,403],"treated":[262,359],"effects":[266,431],"further":[274],"supported":[275],"Western":[277],"blot":[278],"showing":[280],"CDK4":[285],"CDK6,":[287],"necessary":[290],"progression":[294],"from":[295,441],"phase.":[298],"We":[299],"have":[300,379],"found":[302],"results":[307],"\u03b2-catenin":[312],"TE10":[314],"cells,":[315],"suggesting":[316],"affecting":[321],"pathway":[323],"cause":[325],"tumor":[329,349,370,387,405,410,448,474],"cells.":[330,406],"Finally,":[331],"used":[333],"our":[334],"ESO1":[335],"mouse":[336],"squamous":[338],"xenograft":[345],"study":[346],"were":[351],"injected":[352],"into":[353],"flanks":[355],"mice.":[357],"Mice":[358],"intraperitoneal":[361],"injections":[362],"300":[364],"mg/m2":[365],"had":[368],"smaller":[369],"volumes":[371],"compared":[372],"untreated":[374],"controls.":[375],"In":[376,423],"summary,":[377],"shown":[380],"inhibits":[383,470],"both":[389],"vitro":[391,443,477],"vivo.":[394],"Our":[395],"data":[396],"suggest":[397],"induces":[400],"may":[413],"be":[414],"downregulation":[417],"WNT/\u03b2-catenin":[420],"signaling":[421],"pathway.":[422],"future":[424],"studies,":[425],"plan":[427],"analyze":[429],"other":[435],"components":[436],"WNT":[439],"family":[440],"as":[445,447],"well":[446],"xenografts.":[449],"Citation":[450],"Format:":[451],"Randi":[452],"J.":[453],"Ryan,":[454],"Prabhu":[455],"Ramamoorthy,":[456],"Dharmalingam":[457],"Subramaniam,":[458],"Shrikant":[459],"Anant,":[460],"Scott":[461],"Weir.":[462],"olamine:":[464],"A":[465],"common":[466],"vivo":[480],"[abstract].":[481],"In:":[482],"Proceedings":[483],"American":[486],"Association":[487],"Cancer":[489,502],"Research":[490],"Annual":[491],"Meeting":[492],"2018;":[493],"2018":[494],"Apr":[495],"14-18;":[496],"Chicago,":[497],"IL.":[498],"Philadelphia":[499],"(PA):":[500],"AACR;":[501],"Res":[503],"2018;78(13":[504],"Suppl):Abstract":[505],"nr":[506],"2865.":[507]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2018-08-22T00:00:00"}